How Should the Impact of Different Presentations of Treatment Effects on Patient Choice Be Evaluated? A Pilot Randomized Trial

• Cheryl Carling ,

  * E-mail: cheryl.carling@kunnskapssenteret.no

  Affiliation Norwegian Knowledge Centre for the Health Services, Oslo, Norway

  ⨯
• Doris Tove Kristoffersen,

  Affiliation Norwegian Knowledge Centre for the Health Services, Oslo, Norway

  ⨯
• Jeph Herrin,

  Affiliation Department of Medicine, Yale University School of Medicine, New Haven, Connecticut, United States of America

  ⨯
• Shaun Treweek,

  Affiliation Norwegian Knowledge Centre for the Health Services, Oslo, Norway

  ⨯
• Andrew D. Oxman,

  Affiliation Norwegian Knowledge Centre for the Health Services, Oslo, Norway

  ⨯
• Holger Schünemann,

  Affiliation Clinical Research and INFORMAtion Translation Unit, and Department of Epidemiology, Italian National Cancer Institute Regina Elena, Rome, Italy

  ⨯
• Elie A. Akl,

  Affiliation Department of Medicine, State University of New York at Buffalo, Buffalo, New York, United States of America

  ⨯
• Victor Montori

  Affiliation Knowledge and Encounter Research Unit, Division of Endocrinology and Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota, United States of America

  ⨯